Loading clinical trials...
Loading clinical trials...
Open-Label Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia
Conditions
Interventions
Valbenazine
Locations
27
United States
Anaheim, California, United States
National City, California, United States
Norwalk, California, United States
Oakland, California, United States
San Bernardino, California, United States
San Diego, California, United States
Start Date
June 13, 2016
Primary Completion Date
June 30, 2017
Completion Date
June 30, 2017
Last Updated
December 19, 2018
NCT07173920
NCT06997198
NCT05859698
NCT06474650
NCT05238701
NCT02198794
Lead Sponsor
Neurocrine Biosciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions